The combined effects of zoledronic acid (ZOL) and doxorubicin (DOX) on breast cancer cell invasion in vitro

被引：0
|
作者：
Woodward, J [1 ]
Coleman, R [1 ]
Neville-Webbe, H [1 ]
Holen, I [1 ]
机构：
[1] Univ Sheffield, Sch Med, Sheffield S10 2TN, S Yorkshire, England
来源：
CANCER TREATMENT REVIEWS | 2005年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
79
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [1] Combined effects of zoledronic acid and doxorubicin on breast cancer cell invasion in vitro
    Woodward, JKL
    Neville-Webbe, HL
    Coleman, RE
    Holen, I
    [J]. ANTI-CANCER DRUGS, 2005, 16 (08) : 845 - 854
  • [2] Zoledronic acid (ZOL) in combination with doxorubicin (DOX) has synergistic effects on apoptosis of breast cancer cells (BCCs) in vitro
    Neville-Webbe, HL
    Evans, CA
    Coleman, RE
    Holen, I
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (09) : 1598 - 1598
  • [3] The effects of zoledronic acid and doxorubicin in combination on breast cancer cell invasion in vitro
    Woodward, JKL
    Neville-Webbe, H
    Coleman, RE
    Holen, I
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (07) : 1299 - 1299
  • [4] Understanding drug-sequence-dependent synergistic induction of apoptosis by zoledronic acid (ZOL) and doxorubicin (DOX) in breast cancer
    Neville-Webbe, HL
    Coleman, RE
    Holen, I
    [J]. CANCER TREATMENT REVIEWS, 2005, 31 : S41 - S41
  • [5] Understanding drug-sequence-dependent synergistic induction of apoptosis by zoledronic acid (ZOL) and doxorubicin (DOX) in breast cancer
    Neville-Webbe, HL
    Coleman, RE
    Holen, I
    [J]. CANCER TREATMENT REVIEWS, 2005, 31 : S28 - S28
  • [6] Presence of BRCA1 gene enhances levels of apoptosis induced by combination treatment with doxorubicin (DOX) and zoledronic acid (ZOL).
    Neville-Webbe, HL
    Evans, A
    Coleman, RE
    Holen, I
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S73 - S73
  • [7] Synergistic effects of zoledronic acid and doxorubicin in breast cancer models in vivo
    Ottewell, P. D.
    Jones, M.
    Coleman, R. E.
    Holen, I.
    [J]. CANCER TREATMENT REVIEWS, 2006, 32 : S30 - S30
  • [8] Antitumor effects of doxorubicin followed by zoledronic acid in a mouse model of breast cancer
    Ottewell, Penelope D.
    Monkkonen, Hannu
    Jones, Mark
    Lefley, Diane V.
    Coleman, Robert E.
    Holen, Ingunn
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (16) : 1167 - 1178
  • [9] Effects of zoledronic acid (ZOL) on proliferation of nasopharyngeal carcinoma (NPC) cell lines and synergistic effects of ZOL and cisplatin on NPC cell lines
    Ghimire, B. R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [10] Effect of metronomic use of zoledronic acid (ZOL) on antitumor and antiosteoclastic effects in breast cancer patients with bone metastasis
    Xi-Chun, H.
    Zhao, X.
    Xu, X.
    Guo, H.
    Wang, Z.
    Guo, X.
    Chen, J.
    Wu, J.
    Shao, Z.
    Li, J.
    Zhu, B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345